(Q33689432)

28 July 2017

title

Increased regimen durability in the era of once-daily fixed-dose combination antiretroviral therapy (English)

1 reference

28 July 2017

main subject

anti-retroviral agent

0 references

Andrew O Westfall

3

0 references

Jeroan J. Allison

object named as

Jeroan Allison

7

0 references

Michael Saag

11

object named as

Michael S Saag

1 reference

28 July 2017

12

Michael J Mugavero

1 reference

28 July 2017

1

James H Willig

1 reference

28 July 2017

2

Sarah Abroms

1 reference

28 July 2017

8

Ashlee Chatham

1 reference

28 July 2017

5

Sunil Adusumilli

1 reference

28 July 2017

Justin Routman

4

1 reference

28 July 2017

Mohit Varshney

6

1 reference

28 July 2017

James L Raper

9

1 reference

28 July 2017

Richard A Kaslow

10

1 reference

28 July 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

28 July 2017

1 reference

28 July 2017

volume

22

1 reference

28 July 2017

issue

15

1 reference

28 July 2017

page(s)

1951-1960

1 reference

Translating efficacy into effectiveness in antiretroviral therapy: beyond the pill count

28 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

The effect of adherence on the association between depressive symptoms and mortality among HIV-infected individuals first initiating HAART.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

CD4+ count-guided interruption of antiretroviral treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Trials that matter: CD4+ T-lymphocyte count-guided interruption of antiretroviral therapy in HIV-infected patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

High frequency of highly active antiretroviral therapy modifications in patients with acute or early human immunodeficiency virus infection

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Estimating the length of the first antiretroviral therapy regiment durability in São Paulo, Brazil

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Reasons for Stopping Antiretrovirals Used in an Initial Highly Active Antiretroviral Regimen: Increased Incidence of Stopping Due to Toxicity or Patient/Physician Choice in Patients with Hepatitis C Coinfection

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2828871

Duration of Highly Active Antiretroviral Therapy Regimens

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18784459

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Tratamiento antirretroviral de la infección por el virus de la inmunodeficiencia humana: duración y motivos de cambio del primer esquema terapéutico en 518 pacientes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18784459

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/QAD.0B013E32830EFD79

1 reference

28 July 2017

1 reference

28 July 2017

1 reference